Koyfin Home > Directory > Health Care > Intellia Thera CS > Net Debt / EBITDA

Intellia Thera CS Net Debt / EBITDA Chart (NTLA)

Intellia Thera CS annual/quarterly Net Debt / EBITDA from 2014 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Intellia Thera CS Net Debt / EBITDA for the quarter ending June 06, 2020 was $4m a 9.46% increase of 0m year over year
  • Intellia Thera CS Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $4m a 15.04% increase of 1m year over year
  • Intellia Thera CS Annual Net Debt / EBITDA for 2019 was $3m a -24.41% decrease of -1m from 2018
  • Intellia Thera CS Annual Net Debt / EBITDA for 2018 was $4m a -40.82% decrease of -1m from 2017
  • Intellia Thera CS Annual Net Debt / EBITDA for 2017 was $5m a -71.79% decrease of -4m from 2016
Other Ratios Metrics:
  • Intellia Thera CS Other Liabilities for the quarter ending September 09, 2018 was $32m a -38.16% decrease of -12m year over year
View Chart On Koyfin

Quarterly NTLA Net Debt / EBITDA Data

06/2020$4m
03/2020$2m
12/2019$3m
09/2019$3m
06/2019$3m
03/2019$3m
12/2018$4m
09/2018$3m
06/2018$3m
03/2018$4m

Annual NTLA Net Debt / EBITDA Data

2019$3m
2018$4m
2017$5m
2016$9m
2015$6m
2014$2m